If amphotericin B is administered, the patient should be premedicated with:
Amphotericin B works by binding to ergosterol in fungal cell membranes, creating pores that lead to cell death. But in humans, it might interact with cholesterol in our cell membranes, causing toxicity. The main side effects are fever, chills, hypotension, and nephrotoxicity. So premedication is given to prevent or reduce these reactions.
Now, the correct answer is likely an antihistamine or corticosteroid. Common premedication includes antihistamines like diphenhydramine (Benadryl) and sometimes corticosteroids like dexamethasone. Maybe also an antiemetic like ondansetron. But the question is asking for the specific premedication. Let me check standard protocols. Oh right, the typical premedication is antihistamines and corticosteroids before the infusion starts. So the correct answer is probably an antihistamine like diphenhydramine.
Looking at the options, if the correct answer is C, which is diphenhydramine, then the wrong options might be other drugs. For example, A could be a beta blocker, which isn't used for this. B might be an ACE inhibitor for nephrotoxicity, but that's not premedication. D could be an opioid, which isn't relevant here. Each incorrect option needs to be explained why it's wrong.
Clinical pearl: Always premedicate with antihistamines and corticosteroids before amphotericin B to prevent infusion reactions. Also, using lipid formulations might reduce some side effects. The key point is the premedication to manage the acute reactions.
**Core Concept**
Amphotericin B, a polyene antifungal agent, causes dose-limiting infusion-related reactions (fever, chills, hypotension) and nephrotoxicity. Premedication with **antihistamines** and **corticosteroids** mitigates these reactions by blocking inflammatory pathways and stabilizing mast cells.
**Why the Correct Answer is Right**
**Diphenhydramine** (an H1 antihistamine) is administered pre-infusion to counteract histamine release triggered by amphotericin B. Histamine-mediated vasodilation and bronchoconstriction are key drivers of chills and hypotension. Corticosteroids (e.g., dexamethasone) further suppress cytokine release (e.g., TNF-Ξ±, IL-1Ξ²), reducing systemic inflammation. This combination is standard for first-dose reactions.
**Why Each Wrong Option is Incorrect**
**Option A:** Beta-blockers are contraindicated due to risk of unopposed alpha-adrenergic effects (e.g., severe vasoconstriction).
**Option B:** ACE inhibitors are post-infusion strategies for nephrotoxicity, not premedication.
**Option D:** Opioids may mask hypotension but do not prevent histamine/cytokine-mediated reactions.